#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Kidney transplant rejection Squamous cell carcinoma of head and neck Chronic myelomonocytic leukaemia Squamous cell carcinoma of the hypopharynx Small intestine adenocarcinoma Stiff person syndrome Hepatic angiosarcoma Synovial sarcoma recurrent Juvenile idiopathic arthritis Hyperphagia Loss of consciousness Urea cycle disorder Type IIa hyperlipidaemia B-cell small lymphocytic lymphoma Neoplasm More trials…

    Learn about Rare Diseases

    Fragile X syndrome – Diagnostics Rhabdoid tumour – Diagnostics Toxic epidermal necrolysis Burkitt’s lymphoma Mitochondrial myopathy – Diagnostics Indolent systemic mastocytosis – Trials in Disease Medulloblastoma – Treatment Sarcoma – Life with Disease Cholangitis sclerosing – Trials in Disease Hairy cell leukaemia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fenofibrate Micronised Tanimilast AAV9-CTNT-COBAG3 Quetiapine Mirabegron Methoxyflurane Colistin Sulfate Lymecycline TETANUS TOXOID Vibosameran Sodium Oxybate Semaglutide Posdinemab Timrepigene Emparvovec D-Camphor SODIUM FUSIDATE Lisaftoclax Brinzolamide Juniper Berry Oil 12 Grass Pollen Mixture More therapies…

    Learn about Your Condition

    Metastatic malignant melanoma Postpartum haemorrhage Pneumonia chlamydial Synovial sarcoma metastatic Hyperthyroidism Food allergy Triple negative breast cancer Liver transplant rejection Colon cancer stage IV Phaeochromocytoma Cholestatic pruritus Plasma cell leukaemia Gestational diabetes Mucosal inflammation Methylmalonic acidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hepatic cancer

  • Study of intra-arterial angiotensin II during radioembolization to improve treatment effectiveness in patients with primary or secondary liver cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic cancer
    Investigated Drugs:
    • ANGIOTENSIN II
    The Netherlands

  • Study on Indocyanine Green for Better Detection of Liver Tumors in Patients Undergoing Minimally Invasive Liver Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Indocyanine Green
    Spain

  • Evaluating the use of technetium (99mTc) galactosyl serum albumin to predict complications in patients undergoing surgery for liver tumors

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Hepatic cancer
    Denmark

  • Study on Atezolizumab for Patients with Lung and Liver Cancer Using Digital Health Solutions

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Hepatic cancer
    Investigated Drugs:
    • Atezolizumab
    Austria Germany Spain

  • Study on Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Liver, Colon, Pancreatic, Bile Duct, Gallbladder, Endometrial, or Esophageal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Bile duct cancer
    • Colon cancer
    • Gallbladder cancer
    Investigated Drugs:
    • Belzutifan
    • Lenvatinib
    • Pembrolizumab
    Belgium France The Netherlands Spain

  • Study on Adding Ipilimumab to Atezolizumab and Bevacizumab for Patients with Liver Cancer Receiving First-Line Treatment

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Hepatic cancer
    Investigated Drugs:
    • Ipilimumab
    • Atezolizumab
    • Bevacizumab
    France
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!